Trifluoroacetic acid → HCID 86590804, compound
Reaction equation
C([O:3][CH:4]1[CH:8]([NH:9][C:10]([C@H:12]2[N:23]3[C@@H:16]([CH2:17][CH2:18][CH2:19][CH2:20][C@H:21]([NH:25][C:26](=[O:33])[C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=4)[C:22]3=[O:24])[CH2:15][N:14]([C:34](=[O:36])[CH3:35])[CH2:13]2)=[O:11])[CH2:7][C:6](=[O:37])[O:5]1)C.FC(F)(F)C(O)=O>C(#N)C.O>[OH:3][CH:4]1[CH:8]([NH:9][C:10]([C@H:12]2[N:23]3[C@@H:16]([CH2:17][CH2:18][CH2:19][CH2:20][C@H:21]([NH:25][C:26](=[O:33])[C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=4)[C:22]3=[O:24])[CH2:15][N:14]([C:34](=[O:36])[CH3:35])[CH2:13]2)=[O:11])[CH2:7][C:6](=[O:37])[O:5]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of (4S,6S,10aS)-2-acetyl-6-benzoylamino-5-oxo-decahydro-2,4a-diaza-benzocyclooctene-4-carboxylic acid (2-ethoxy-5-oxo-tetrahydrofuran-3-yl)amide, 11, (70 mg, 0.14 mmol) in acetonitrile/water is treated with trifluoroacetic acid. After stirring for 30 minutes the solution is concentrated in vacuo and the crude product purified by preparative reverse phase HPLC to afford 36 mg of the desired product as a white solid. 1H NMR (CD3OD) δ 7.90 (d, J=6.9 Hz, 2H), 7.52 (m, 3H), 5.2–4.2 (series of m, 7H), 3.40 (m, 1H), 3.18 (m, 1H), 2.8–1.2 (series of m, 12H), 2.35 (s, 3H); MS 487 (M+H)+.
Workup
- concentrationis concentrated in vacuo
- customthe crude product purified by preparative reverse phase HPLC
Sources & evidence
- ORD record
- ord-3ee7cece445840ca968e8ec1ade73885
- Source dataset
- uspto-grants-2006_11
- Patent number
- US07138395B2
Reaction notes
Loading…